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The New Delhi metallo-β-lactamase (NDM-1) is an important clinical target for antimicrobial
research, but there are insufficient clinically useful inhibitors and the details of NDM-1 en-
zyme catalysis remain unclear. The aim of this work is to provide a thermodynamic profile
of NDM-1 catalysed hydrolysis of β-lactams using an isothermal titration calorimetry (ITC)
approach and to apply this newmethod to the identification of new low-molecular-weight di-
carboxylic acid inhibitors. The results reveal that hydrolysis of penicillin G and imipenem by
NDM-1 share the same thermodynamic features with a significant intrinsic enthalpy change
and the release of one proton into solution, while NDM-1 hydrolysis of cefazolin exhibits a
different mechanism with a smaller enthalpy change and the release of two protons. The
inhibitory constants of four carboxylic acids are found to be in the micromolar range. The
compounds pyridine-2,6-dicarboxylic acid and thiazolidine-2,4-dicarboxylic acid show the
best inhibitory potency and are confirmed to inhibit NDM-1 using a clinical strain of Es-
cherichia coli. The pyridine compound is further shown to restore the susceptibility of this
E. coli strain to imipenem, at an inhibitor concentration of 400 μM, while the thiazoline com-
pound also shows a synergistic effect with imipenem. These results provide valuable infor-
mation to enrich current understanding on the catalytic mechanism of NDM-1 and to aid the
future optimisation of β-lactamase inhibitors based on these scaffolds to tackle the problem
of antibiotic resistance.
Introduction
β-Lactam antibiotics (Figure 1A), including penicillins (e.g. penicillin G), cephalosporins (e.g. cefazolin),
monobactams and carbapenems (e.g. imipenem), are themost widely used agents for treating clinical bac-
terial infections [1]. Among these, carbapenems, featuring a five-membered ring fused to the β-lactam
core structure, are an important class of β-lactam antibiotics widely used in the treatment of serious
bacterial infections caused by bacteria expressing extended-spectrum β-lactamases (ESBLs) [2,3]. How-
ever, the overuse of this class of antibiotic has led to decreased bacterial susceptibility towards these
compounds, mostly via mechanisms such as antibiotic inactivation by carbapenemases, reduced bacte-
rial membrane permeability, altered penicillin binding proteins (PBPs) and/or efflux of antibiotics [4-8].
Of these mechanisms, production of carbapenemases poses the most serious threat, not only because
carbapenemase-producing bacteria tend to have higher level of resistance to carbapenems, but also be-
cause the carbapenemase gene in mobile genetic elements is easy to transfer across species, giving rise to
nosocomial outbreaks of carbapenem-resistant pathogens [9]. According to amino acid homologies, car-
bapenemases have been classified into A, B and D groups in the Ambler system. Class A and D enzymes
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Figure 1. Structures of representative β-lactam antibiotics and carboxylic acid inhibitors
D-Captopril 1, salicylic acid derivative 2, ME1071 3, AMA 4, D-(−)-tartaric acid 5, fumaric acid 6, pyridine-2,6-dicarboxylic acid 7
and rac-thiazolidine-2,4-dicarboxylic acid 8.
contain a catalytic serine residue in the active site to aid the hydrolysis of the C–N bond through formation of a
covalent acyl-enzyme adduct, whereas class B enzymes (metallo-β-lactamases, MβLs) require the presence of zinc
to activate water for nucleophilic attack on the substrate [10].
Currently, several inhibitors of serine-β-lactamases, including clavulanic acid, sulbactam and tazobactam have
been clinically approved to work in synergy withβ-lactams, while others (e.g. avibactam and MK-7655) are in clinical
trial. While such combination therapy is useful in tackling infections due to serine-β-lactamases, there are currently
no inhibitors approved for use against bacteria harbouring MβLs [11-14]. Of particular clinical importance, New
Delhi metallo-β-lactamase-1 (NDM-1), first discovered in 2008 in a strain of Klebsiella pneumoniae isolated in
India, is now one of the most abundant MβLs in clinic [15,16]. It has been found in species of Enterobacteriaceae,
Acinetobacter baumannii, Vibrio cholerae, Stenotrophomonas and Pseudomonas aeruginosa, and accounts for
60% of autochthonous human infection isolates according to a survey of data from 2009 to 2012 [16,17]. Hence, a
mechanistic study [18-20] of NDM-1 and the design of potent NDM-1 inhibitors for combination therapy are active
areas for antimicrobial research [21].
Among the reported NDM-1 inhibitors, carboxylic acid-containing compounds are one of the most prominent
categories [22,23]. D-Captopril 1 (Figure 1B) has been shown to be a potent competitive inhibitor of NDM-1 with Ki
1.3μM [24,25], while a salicylic acid derivative 2was predicted to inhibit NDM-1 in amolecular docking study [26]. A
maleic acid substituteME1071 3was reported to inhibitNDM-1with aKi of 24μM [27]. King et al. identified a natural
product AMA 4 as a potent inactivator of NDM-1 with a Ki value of 11 nM and an IC50 of 4.0 μM [28,29]. Hence,
it is important to investigate whether even simpler carboxylic acid derivatives may have good inhibitory potency for
further development of clinical NDM-1 inhibitors.
Isothermal titration calorimetry (ITC) is a powerful technique capable of measuring real-time heat change rates
in enzyme-catalysed reactions, a parameter directly proportional to the reaction rate which has thus become widely
used for enzyme thermodynamic and kinetic studies [30-35]. However, this technique has not received much atten-
tion in work on MβLs. We have recently developed an ITC assay to study the thermokinetics of a B3 subclass MβL
L1 and our results demonstrate that the calorimetric approach is a simple and efficient method in evaluating the ki-
netics of β-lactam hydrolysis. It has the additional advantages of being able to provide valuable information on the
thermodynamic nature of enzyme catalysis, being compatible with optically turbid bacterial suspensions in contrast
with conventional UV spectroscopy [36]. In this work, we sought to apply this calorimetric approach to a mechanis-
tic study of a clinically relevant NDM-1 in the B1 subclass of MβLs, using three representative β-lactams: penicillin
G, cefazolin and imipenem. In the second part of this work, the inhibitory potencies of four low-molecular-weight
dicarboxylic acid compounds on NDM-1 were investigated. Of the compounds studied, D-(−)-tartaric acid 5 and
fumaric acid 6 are two natural dicarboxylates with structural resemblance to 3 and 4. Pyridine-2,6-dicarboxylic acid
7was reported to be an effective inhibitor of IMP-1 and CphA [37]. Recently, derivatives of 7were demonstrated to be
highly selective inhibitors for B1 MβLs [38]. Thiazolidine-2,4-dicarboxylic acid 8was shown to have a powerful effect
on CcrA, Imis and L1 activities [39,40]. It is generally believed that carboxylate compounds exert the inhibitory effect
via interaction with active site zinc atoms and current data have revealed a significant degree of selectivity of these
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compounds between different MβLs [39]. Hence, an evaluation of carboxylates 5–8 on NDM-1 provides valuable
information for the exploration of promising scaffolds and the development of broad-spectrum inhibitors of MβLs.
Given that NDM-1 remains a global challenge in medicinal chemistry, characterisation of this clinically important
enzyme using a calorimetric approach will give strong support to ongoing studies on the mechanism and inhibition
of NDM-1.
Materials and methods
Enzyme and reagents
Antibiotics (>98% purity) were purchased from Sigma–Aldrich Trading Co. Ltd (Shanghai, China). Compounds 1
(98% purity) and 5–7 were from the Aladdin Industrial Corporation (Shanghai, China). Compound 8 was from J&K
Scientific Ltd (Beijing, China). All other chemicals were analytical grade. The expression plasmid pET26b–NDM-1
[41] for the production of recombinant NDM-1 enzyme was a kind gift from Professor Michael Crowder at Miami
University, Florida, USA. Escherichia coli ATCC25922 was purchased from the American Type Culture Collection
(ATCC). The clinical E. coli strain used was isolated from a blood culture of one individual patient in the First Affil-
iated Hospital of Xi’an Jiaotong University (Xi’an, China), and had previously been confirmed by DNA sequence to
produce NDM-1 (unpublished data).
NDM-1 gene expression and protein puriﬁcation
Recombinant NDM-1 was produced and purified as previously described [41]. Briefly, recombinant E. coli cells con-
taining the NDM-1 gene in pET26b plasmid were grown in Lysogeny Broth (LB) medium supplemented with 25
μg/ml kanamycin at 37◦C and gene expression was induced by adding 1 mM IPTG and 50 μM ZnCl2. The culture
was incubated overnight at 20◦C before cells were harvested and then lysed by sonication. Protein was first loaded
on a Q-Sepharose ion exchange column and eluted with a gradient of 0–500 mM NaCl in 30 mM Tris–HCl, pH 8.0.
A Superdex 75 size exclusion column was used to further purify the target protein in the buffer of 30 mM Tris–HCl,
pH 7.5 and 200 mM NaCl. The purity of fractions containing NDM-1 protein was checked using SDS–PAGE, and
the concentration of purified protein was determined using UV-spectroscopy with extinction coefficient 27960 M−1
cm −1 at 280 nm.
UV-spectroscopic assay
IC50 values of compounds 1 and 5–8 were determined using a spectroscopic method [42]. Assays were carried out
using an Agilent UV 8453 spectroscopy at 25◦C, with 60 μM penicillin G as a substrate in a total volume of 1 ml
buffer (50 mM Tris–HCl, pH 7.0, 100 mM NaCl). Reactions were initiated by addition of NDM-1 enzyme to a final
concentration of 20nM and changes in absorbance of penicillinG at 205nmwere recorded continuously for 30 s. Rates
were also determined in the presence of inhibitor by pre-incubation with the enzyme for 30 min at RT before starting
kinetic experiments. IC50 values were determined usingGraphPad Prism5 software (GraphPadSoftware, La Jolla,CA,
USA) by plotting percentage of inhibition against inhibitor concentration; average values from three measurements
are reported.
Calorimetric assays
Enzyme kinetics of NDM-1 and inhibition studies by carboxylic acid compounds were conducted using an ITC-200
calorimeter (Malvern Instruments Ltd., UK), with a reference cell loaded with deionised water and experiments car-
ried out at 25◦C with a stirring speed of 750 rpm.
To obtain the apparent enthalpy change (Happ) of enzyme-catalysed hydrolysis of antibiotics (penicillin G, ce-
fazolin or imipenem), experiments were performed by injecting 20 μl of 1 mM antibiotic solution, preloaded in the
syringe, into a sample cell filled with 210 μl of 50 nM purified NDM-1 in buffer of 50 mM Tris–HCl, pH 7.0, 100
mM NaCl. Real-time changes of heat-flow were recorded continuously until return to baseline. Control experiments
were performed by titrating substrate to buffer and using those data in corrections for heat of dilution before values
ofHapp were determined using the embedded Origin software, by dividing integrated heat by the molar quantity of
substrate converted according to (eqn 1), where dQ/dt is the rate of heat production, V is the volume of the sample
cell and [S]t = 0 is the substrate concentration:
H =
∫ ∞
t=0
dQ
dt dt(
V[S](t=0)
) (1)
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Experiments were also repeated in HEPES and phosphate buffers and the intrinsic enthalpy change (Hint) of the
reactions calculated according to (eqn 2) by plotting the measured Happ as a function ofHion, whereHion is the
ionisation enthalpy of the buffer used and n represents the number of exchanging protons. The values ofHion used
in the calculation wereHion (Tris–HCl)= 11.34 kcal/mol,Hion (HEPES)= 4.88 kcal/mol and Hion (phosphate)
= 0.86 kcal/mol [43].
Happ = Hint + nHion (2)
For steady-state kinetics of NDM-1, experiments were conducted in multi-injection mode, with 10 nM NDM-1 in
the sample cell and 10 mM antibiotic (penicillin G, cefazolin or imipenem) in the syringe, both in buffer of 50 mM
Tris–HCl, pH 7.0, 100 mM NaCl. Successive injections of antibiotic into the sample cell were made at 120 s intervals.
Following (eqn 3), the change in thermal power (dQ/dt) from each titration was converted into the reaction rate
(υ). These rates were used to fit to the Michaelis–Menten equation (eqn 4) to obtain the kinetic parameters KM
(Michaelis–Menten constant) and kcat (turnover rates), where [E]tot is the total concentration of active enzyme.
υ = dP
dt
= 1
V Happ
· dQ
dt
(3)
υ = kcat[E]tot [S]
KM + [S] (4)
Inhibition studies for NDM-1 with compounds 1 and 5–8 using calorimetric assay were performed by
pre-incubating NDM-1 with the corresponding compound for 30 min prior to starting a multi-injection experiment
with penicillin G, as described above. The concentrations of substrate and NDM-1 were the same as for the kinetic
assay. Concentrations used for 1 were 2 and 20 μM, for 5 were 1 and 2 mM, for 6 were 100 μM and 1.5 mM, for 7
were 1 and 5 μM and for 8 were 2 and 10 μM. Competitive (Kic) and uncompetitive (Kiu) inhibition constant val-
ues for each inhibitor were obtained by fitting calculated reaction rates (υ) at different inhibitor concentrations to
(eqn 5) using nonlinear regression analysis in Origin software (embedded with ITC), with Kic and Kiu set as shared
parameters between all datasets, inhibitor concentration [I], [E]tot, [S] as independent variables and υ as dependent
variable.
υ = kcat[E ]tot [S]
[S]
(
1 + [I]K iu
)
+ Km
(
1 + [I]K ic
) (5)
Cell-based calorimetric assays were performed using a clinical E. coli strain expressing NDM-1 gene (E.
coli–NDM-1) and a reference bacterial strain ATCC 25922 (β-lactamase negative). Experiments were performed
as above, except that bacterial suspensions were added to the sample cell of the calorimeter at a concentration of 1
OD in the absence and presence of 500 μM 1, 7 and 8, prepared in 50 mM Tris–HCl, pH 7.0, 100 mM NaCl buffer
supplement with 0.1% Triton. The raw calorimetric signal was obtained after all penicillin G (20 μl of 1 mM) was
injected.
MIC determinations
The efficacies of compounds 1, 7 and 8 to work in synergy with an antibiotic were investigated by determining the
minimum inhibitory concentrations (MICs) of imipenem towards the above clinical E. coli–NDM-1 strain using a
broth microdilution method according to guidelines of the Clinical and Laboratory Standards Institute (CLSI) [44].
Single colonies of E. coli–NDM-1were used to inoculateMueller–Hintonmediumandwere grown at 37◦C overnight.
A volume of 100 μl of diluted bacteria culture at a density of 106 colony forming units (CFU) per ml was added
to a series of 2-fold diluted imipenem solutions prepared in 100 μl Mueller–Hinton medium, in the presence of
compounds 1, 7 and 8 at 0, 200 and 400 μM. Results were obtained after incubating the microtitre plate at 37◦C for
a further 18 h and turbidity of bacterial growth was recorded using a plate reader.
Results and discussion
A single injection calorimetric experimentwas performed to record the real-time heat change associatedwithNDM-1
catalysed hydrolysis ofβ-lactams and a raw calorimetric trace of titrating 20 μl of 1 mM penicillin G into 210 μl of 50
nM NDM-1 in Tris–HCl, pH 7.0 buffer is shown (Figure 2A). The negative change in heat-flow shows the reaction is
exothermic. The largest displacement of the baseline (120–160 s, Figure 2A) corresponds to the maximum catalytic
rate under enzyme saturation conditions, while the decay portion of the curve (160–300 s) reflects gradual depletion
4 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 2. Calorimetric thermogram for the titration of penicillin G with NDM-1 in a single injection ITC assay and the deter-
mination of the intrinsic enthalpy of reaction (Hint)
(A) Raw thermal power measured by titrating 20 μl of 1 mM penicillin G into 60 nM NDM-1 protein or buffer (control) at 25◦C. (B)
Determination of the intrinsic enthalpy change (Hint) of penicillin G catalysed by NDM-1 with linear regression of the apparent
enthalpy change (Happ) for penicillin G over the protonation enthalpy of each buffer (Hion) to give the intercept for Hint and the
slope for the number of protons (n) exchanged during catalysis.
Table 1 Thermodynamic and kinetic data of the hydrolysis of three β-lactam antibiotics catalysed by NDM-1 derived using
ITC.
Compound
Happ
(kcal/mol) n
Hint
(kcal/mol) kcat (s−1) KM (μM)
kcat/Km (s−1
μM−1)
kcat/KM-UV1 (s−1
μM−1)
Penicillin G −27.9 +− 0.01 −0.87 +− 0.10 −18.3 +− 0.73 54 +− 1 139 +− 12 0.39 0.68
Cefazolin −28.3 +− 0.97 −1.89 +− 0.04 −5.20 +− 0.04 42 +− 1 237 +− 14 0.18 −
Imipenem −32.5 +− 0.08 −1.24 +− 0.02 −18.4 +− 0.12 23 +− 1 168 +− 28 0.14 0.21
1From Yong et al. [15] using the traditional UV-spectroscopic assay. Reactions were performed at 30◦C in buffer 10 mM HEPES, pH 7.5.
of the substrate until fully consumed. The apparent enthalpy change (Happ) of each reaction was calculated by
integrating the area under the entire titration curve and normalised for substrate consumed (in moles). The Happ
values for NDM-1 catalysed hydrolysis of penicillin G, cefazolin and imipenem at pH 7.0, 25◦C were determined to
be –27.9, –28.3 and –32.5 kcal/mol, respectively (Table 1). The measured heat reflects the total enthalpy of all events
in the reaction vessel, including both the intrinsic enthalpy change of the reaction and the ionisation enthalpy of
the buffer used. To determine the Hint of each antibiotic, the reaction was performed in buffers having different
ionisation enthalpies at pH 7.0. By plotting Happ as a function of Hion specific to each buffer used (Figure 2B),
it is apparent that there is a decrease in Happ with the increase of Hion, indicating NDM-1 catalysed hydrolysis
of penicillin G involves exchanging of proton(s) with the buffer solution. The same result was obtained for cefazolin
and imipenem. The number of exchanging protons (n) was determined as the slope of the fitted plots,−0.87 (+− 0.10)
for penicillin G and −1.24 (+− 0.02) for imipenem, in agreement with previous data on metallo-β-lactamase L1 that
approximately one proton is released to bufferduring catalysiswith thedivergence fromunitydepending on the pKa of
the amino group in the hydrolysis product [36]. However, the hydrolysis of cefazolin by NDM-1 apparently involves
a different mechanism, with two protons (n = −1.89 +− 0.04) being taken up by the buffer. The intrinsic enthalpy
(Hint) of each antibioticwasdetermined as theY-axis intercept, and valueswere−18.3+− 0.73 kcal/mol for penicillin
G,−18.4 +− 0.12 kcal/mol for imipenem, and a significantly lower value of−5.20 +− 0.04 kcal/mol for cefazolin. Based
on existing data, the hydrolyses of these β-lactams by NDM-1 involve different processes [45-47]. Since NDM-1
catalysed hydrolysis of penicillin G and imipenem at pH 7.0 are accompanied by a similar intrinsic enthalpy change
and both are associated with the release of one proton, it is reasonable to speculate that these two compounds use the
samemechanism and the proton released is likely derived from ionisation of the new carboxylic acid generated at C-7
after β-lactam ring opening (Figure 3A,B). In comparison, a significant smaller intrinsic enthalpy change and one
additional proton exchanged during cefazolin hydrolysis indicates a different pathway is adopted by NDM-1 in the
hydrolysis of this compound. Indeed, it is known that for some cephalosporins, following the opening of theβ-lactam
ring, the anionic nitrogen intermediate is expected to undergoβ-elimination of the leaving groupwith fragmentation
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Schematic illustration of the proposed catalytic mechanism of NDM-1 towards three β-lactam antibiotics, high-
lighting the difference in number of protons released.
of the initial product [45-48].Hence, it is possible that the intrinsic enthalpy change of cefazolin turnover also involves
heat change in this subsequent elimination reaction and the whole process generates one proton from ionisation of
the new carboxylic acid at C-8 and a second proton from ionisation of the 2-thiothiadizole moiety generated by a
β-elimination of that group from the C-3 side chain (Figure 3C).
The calorimetric data for the titration of NDM-1 with penicillin G following a multiple injection method to obtain
kinetic data is shown (Figure 4A). The process involves 23 successive injections of antibiotic solution into NDM-1
solution. A time interval of 120 s allows the heat flow to reach a brief plateau after each injection tomimic steady-state
conditions of reaction (the enzyme is fully saturated and <5% of the substrate is depleted). Each injection of the
substrate solution further increases the magnitude of heat change offset. The rate of heat change (dQ/dt) at each
substrate concentration was determined as the displacement between the original baseline before the first injection
and the new baseline after each injection. This value was then converted into enzyme turnover rates and fitted to
the Michaelis–Menten equation to obtain the parameters KM and kcat (Figure 4B). As shown in Table 1, NDM-1
has a higher preference for penicillin G (KM = 139 μM) as substrate, followed by imipenem (KM = 168 μM) and
cefazolin (KM = 237 μM), and the overall catalytic efficiency of NDM-1 towards penicillin G (kcat/KM = 0.39 s−1
μM−1) is also 2-fold higher than that of the cefazolin (kcat/KM = 0.18 s−1 μM−1) and almost 3-fold higher than
that of imipenem (kcat/KM = 0.14 s−1 μM−1), at pH 7.0, 25◦C. These results agree with previous data obtained in
a UV-spectroscopic assay where the kcat/KM for penicillin G was determined as 0.68 s−1 μM−1, and the value for
imipenem was determined as 0.21 s−1 μM−1, measured in 10 mM HEPES, pH 7.5 buffer at 30◦C [15].
After the calorimetric assay for steady-state kinetic study of NDM-1 was established, experiments were performed
by pre-incubating different concentrations of inhibitor with NDM-1 for 30 min prior to substrate titration. As shown
(Figure 4B), there is a progressive decrease in enzyme turnover rates with increase in concentration of 7 from 0 to 5
μM. Global fitting of the data to the general inhibition equation gives a competitive inhibition constant Kic of 2.17
+− 0.48 μM and a similar uncompetitive inhibition constant Kiu of 2.07 +− 0.06 μM, showing 7 is a potent mixed
inhibitor of NDM-1. The IC50 value of 7, determined using a conventional UV-spectroscopic method, compares well
with our inhibition data from ITC experiments (Table 2), with an IC50 value of 1.13 +− 0.04 μM for this compound.
Our results, in conjunction with a previous report that the presence of 100 μM of this compound was capable of
reducing enzyme activity of a different class B1 IMP-1 towards imipenem up to 2%, with barely any effect on BcII,
VIM-2, or VIM-4 from the same class of MβLs [37], highlights this compound as having a good degree of selectivity
for enzymes within class B1 MβLs. By comparison, 8 showed a much weaker competitive inhibition constant of Kic
= 152+− 6 μM and a slightly larger uncompetitive inhibition constant of Kiu = 5 +− 0.46 μM (Figure 4C and Table 2),
indicating the mechanism of 8 inhibition at pH 7.0 is predominantly uncompetitive, and the inhibitor binds to the
enzyme–substrate complex instead of to the free enzyme. This Kiu is in good accord with the IC50 of 3.45 +− 0.26 μM
for NDM-1 (Figure 4E), and also in agreement with previous data that this compound is a broad-spectrum inhibitor
of MβLs with strong inhibitory potency towards class B1 CcrA (Ki = 0.64 μM), class B2 ImiS (Ki = 7.1 μM) and class
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Figure 4. Enzyme kinetics and inhibition of NDM-1 catalysed penicillin G hydrolysis using a multiple injection ITC assay and
a UV-spectroscopic assay
(A) Raw heat change observed in the calorimetric assay, obtained by titrating 10 mM penicillin G into 10 nM NDM-1 with 23 in-
jections. (B and D) Global fitting of NDM-1 enzymatic activity in the absence (circles) and presence (triangles and squares) of
compounds 7 and 8 as an enzyme inhibitor using data from the multiple injection ITC assay. Baseline displacement of the ther-
mal power in Figure 4(A) was converted into the reaction rate and plotted according to the Michaelis–Menten equation to obtain
values of KM, kcat, Kic and Kiu. (C and E) IC50 of compounds 7 and 8 determined using a UV-spectroscopic method with inhibitor
concentrations from 16 nM to 40 μM.
Table 2 Inhibition of NDM-1 by carboxylic acid compounds
Inhibitor IC50 (μM)1 Kic (μM)2 Kiu (μM)2
1 2.38 +− 0.64 1.36 +− 0.79 178 +− 21
5 409 +− 16 365 +− 72 993 +− 107
6 232 +− 5 198 +− 50 638 +− 94
7 1.13 +− 0.04 2.17 +− 0.48 2.07 +− 0.06
8 3.45 +− 0.26 152 +− 6 5 +− 0.46
1Data were from the UV-spectroscopic assay in the present study. Experiments were performed at 25◦C in buffer 50 mM Tris–HCl, pH 7.0, 100 mM
NaCl.
2Data were from the ITC inhibition assay in the present study. Experiments were performed at 25◦C in buffer 50 mM Tris–HCl, pH 7.0, 100 mM NaCl.
B3 L1 (Ki = 1.8 μM) [39]. Of the dicarboxylic acid compounds tested, 5 and 6 have the weakest inhibitory activity
towards NDM-1, in a mainly competitive mode, with Kic = 365 +− 72 μM and IC50 = 409 +− 16 μM for 5 and Kic =
198 +− 50 μM and IC50 = 232 +− 5 μM for 6. In addition, as a control, the Kic of 1 was determined to be 1.36 +− 0.79
μM by ITC and the UV-spectroscopic IC50 was 2.38 +− 0.64 μM, which are consistent with previously reported values
of Ki = 1.3 μM and IC50 = 7.9 μM [24,25]. Taken together, the overall ranking of the tested inhibitors agrees well in
both the ITC assay and the UV-spectroscopic assay, with 1, 7 and 8 being the most potent single-digit micro-molar
inhibitors of NDM-1, while 5 and 6 were significantly weaker inhibitors by almost two orders of magnitude.
A cell-based ITC assay was further performed with the more potent compounds 7 and 8, using 1 as a reference,
to ascertain whether these inhibitors can retard NDM-1 hydrolysis of imipenem in a cellular environment using live
bacteria, in a manner similar to the reported UV–vis approach [49]. The raw data of titration of cell suspensions of
a carbapenemase-negative strain (ATCC 25922) with imipenem (Figure 5A) reveal negligible heat change. In com-
parison, titration of imipenem into cell suspensions of an NDM-1–positive clinical E. coli strain (E. coli–NDM-1)
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. Heat ﬂow data for the inhibition of NDM-1 in a cell-based calorimetric assay
(A) Raw calorimetric trace for titrating imipenem (20 μl 1 mM) into suspensions of a reference E. coli (ATCC25922, no β-lactamase
production) at OD = 4 in Tris–HCl buffer. (B) Overlaid calorimetric traces of titrating imipenem (20 μl 1 mM) into suspensions of an
NDM-1-producing clinical E. coli strain at OD = 4 in the absence and presence of 400 μM inhibitors 1, 7 and 8. Control experiment
was performed by injecting buffer into bacterial suspensions.
Table 3 MICs of a clinical E. coli–NDM-1 strain towards imipenem and imipenem-inhibitor combination
MICs (μg/ml) of imipenem in combination with 1, 7 and 8 at various concentrations
0 μM 200 μM 400 μM
E.coli–NDM-1 16
E.coli–NDM-1 + 1 16 16
E.coli–NDM-1 + 7 4 1
E.coli–NDM-1 + 8 16 8
led to a considerable negative change of heat-flow, much like the calorimetric curves with purified NDM-1 (Figure
5B). This strongly suggests that the derived heat-change in the calorimetric assay with E. coli–NDM-1 arises from
enzyme-catalysed hydrolysis of imipenem. Cell-based inhibition assays were then performed by titrating imipenem
with E. coli–NDM-1 in the presence of 400 μM of compounds 1, 7 and 8 (Figure 5B). All tested compounds were
capable of inhibiting the turnover rate of imipenem and postponing the time required for complete consumption of
the substrate, with an efficacy in the order of 7 > 1 > 8. The MICs of imipenem on this clinical E. coli–NDM-1 iso-
late, in the absence and presence of compounds 1, 7 and 8, were next determined (Table 3). The addition of 200–400
μM inhibitors alone showed no effect on bacterial growth, indicating these compounds have no antimicrobial activ-
ity at concentrations tested. However, when 7 and 8 were administered in combination with imipenem, the resistant
strain was re-sensitised towards imipenem. The presence of 400 μM of 7 was able to restore the susceptibility of E.
coli–NDM-1 towards imipenem, by lowering the MICs of imipenem from 16 to 1 μg/ml. Compound 8 at 400 μM
reduced the MICs by 2-fold and shows a weaker synergy with imipenem. Surprisingly, reference compound 1 failed
to show any synergistic effect with imipenem at the tested concentrations, notwithstanding its superior inhibitory
potency in the above in vitro experiments. The possibility of 1 inactivation due to slow oxidation of –SH during
overnight incubation with bacterial suspensions needs to be investigated.
Conclusion
NDM-1 is a class B1 metallo-β-lactamase commonly found in clinical multi-drug resistant pathogens that catalyse
the hydrolysis of β-lactam antibiotics, leading to inactivation of these bactericides. We have used a new ITC ap-
proach to study the thermodynamic data and hydrolytic activity of NDM-1 towards individual β-lactams from three
families, penicillin G, cefazolin and imipenem, coupled to the inhibitory potency of four low-molecular-weight di-
carboxylic acid compounds to promote their activity. Our results reveal that NDM-1 catalysed hydrolysis of penicillin
G, cefazolin and imipenem follow different mechanisms, with cefazolin showing a greatly reduced intrinsic enthalpy
change as well as release of a second proton during β-lactamase turnover. Both ITC and UV-spectroscopic experi-
ments identify pyridine-2,6-dicarboxylic acid and thiazolidine-2,4-dicarboxylic acid as good inhibitors of NDM-1.
These compounds also show good potency in inhibiting NDM-1 hydrolysis of imipenem at the cellular level and
8 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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re-sensitising a clinical strain of E. coli–NDM-1 towards imipenem, suggesting they are promising leads for future
development of more potent inhibitors of NDM-1. The possibility that the activity of pyridine-2,6-dicarboxylic acid
and thiazolidine-2,4-dicarboxylic acid results from zinc coordination is clearly reminiscent of the outstanding devel-
opment of ACE inhibitors such as Captopril from the work of Ondetti and Kushman and merits active development
[50], while recent crystallographic analysis has identified the sulphur atom of Captopril bridging the two zinc atoms
in SMB-1 (PDB: 5aya), and bidentate coordination to a single zinc atom involving sulphur has been exemplified for
blaNDM-1 (PDB: 5a5z) [51], and underpins current work based on cysteine for inhibitor development [52]. The
well-known power of pyridinecarboxylic acids to zinc has been exemplified by picolinic acid for ACC oxidase [53],
but there is no structural report of enzymatic zinc chelation by compound 7. It is thus reasonable to propose that the
inhibitory effect of compounds 7 and 8may result from a combination of monodentate and bidentate coordination
to the two zincs in NDM-1 and merits detailed structural analysis. Compared with D-(−)-tartaric acid and fumaric
acid, the superior inhibitory potency of pyridine-2,6-dicarboxylic acid and thiazolidine-2,4-dicarboxylic acid with
NDM-1 are likely ascribed to two aspects. Firstly, constrains imposed by the pyridine and thiazolidine rings may help
to arrange the attached carboxylate groups for more favourable hydrogen-bonding/ionic interactions with enzyme
active site residues. Secondly, the pyridine and thiazolidine rings may also directly contribute to stronger binding
by making hydrophobic interactions with nonpolar residues at NDM-1 active site. In the perspective of generating
broad-spectrum inhibitors of MβLs for combination therapy, themechanistic complexity of antibiotic hydrolysis and
different modes of inhibitor binding, as highlighted in this work with NDM-1, pose a huge challenge. This work also
endorses the ITC assay as a reliable method to obtain kinetic data on enzyme catalysis and inhibition at both protein
and cellular levels, with the additional advantage of providing important thermodynamic information on enzyme
catalysis. The ITC assay presented here is expected to be adopted as a general method to facilitate mechanistic studies
of other clinical β-lactamases and the evaluation of potential inhibitors.
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